Food Allergy vs Food Intolerance: Immunological Mechanisms (IgE), Enzymatic Deficits, and Differential Diagnostics

Differentiating immunological hypersensitivity from biochemical maldigestion directs critical clinical triage:

• IgE-Mediated Acute Anaphylactic Hypersensitivity: Plasma B-cells synthesize allergen-specific IgE antibodies directed against dietary epitopes (peanut arachin, cow's milk caseins, ovomucoid, shellfish tropomyosin). Cross-linking of high-affinity Fc-epsilon-RI receptors on mast cells and basophils triggers explosive degranulation of histamine, tryptase, and cysteinyl leukotrienes, inducing acute urticaria, laryngeal angioedema, bronchospasm, and distributive circulatory shock within minutes.
• Non-IgE-Mediated Cellular Allergies: Cell-mediated T-lymphocyte driven enteropathies (Food Protein-Induced Enterocolitis Syndrome – FPIES, Eosinophilic Esophagitis – EoE) manifesting subacutely with protracted emesis, mucosal ulcerations, and growth failure.
• Enzymatic and Pharmacological Intolerances: Driven by brush-border hydrolase deficits (lactase non-persistence, sucrase-isomaltase deficiency) or catabolic enzyme saturation (diamine oxidase DAO deficiency in enteral histaminosis). Unabsorbed solutes fuel bacterial fermentation and osmotic fluid shifts proportional to ingested volume.
• The Absolute Threshold Disparity: Anaphylactic allergies can be triggered by microgram-level cross-contamination, whereas intolerances exhibit a classic dose-response curve with benign tolerance beneath individual threshold loads.

Rigorous evidence-based diagnostics prevent unscientific mislabeling and nutritional harm:

• Validated Allergen Identification: Percutaneous skin prick testing (SPT), quantitative serum specific IgE (sIgE), and microarray Component-Resolved Diagnostics (CRD; e.g., ImmunoCAP ISAC or ALEX). CRD distinguishes true life-threatening primary sensitization (e.g., storage proteins Ara h 2 in peanuts) from benign cross-reactive pollen-food syndromes (Bet v 1 homologs).
• The Diagnostic Gold Standard: Double-Blind Placebo-Controlled Food Challenge (DBPCFC), executed under strict tertiary resuscitation preparedness.
• Intolerance Testing via Breath Hydrogen (HBT): Measuring alveolar hydrogen (H2) and methane (CH4) excretion following standardized lactose or fructose boluses, identifying unabsorbed microbial fermentation. Serum diamine oxidase (DAO) activity assays inform histaminosis trials.
• The Fallacy of Food-Specific IgG/IgG4 Panels: Scientific allergy consensus bodies (EAACI, AAAAI) unequivocally condemn commercial food-specific IgG/IgG4 assays. Elevated IgG4 titers represent physiological immunological tolerance and antigen exposure rather than pathology; implementing sweeping exclusions based on IgG results induces severe iatrogenic malnutrition.

Clinical management diverges sharply into emergency anaphylaxis preparedness versus functional enzymatic modulation:

• Emergency Action Protocol for Severe Food Allergy: Patients with documented severe systemic reactions mandate prescription of an emergency auto-injector carrying intramuscular epinephrine (0.3 mg for adults, 0.15 mg for pediatrics) for immediate injection into the anterolateral vastus lateralis. Epinephrine represents the non-negotiable first-line intervention for laryngeal edema and hemodynamic collapse.
• Allergen Vigilance: Total culinary elimination and strict interpretation of mandatory food labeling laws (EU Regulation 1169/2011 covering the 14 major allergens).
• Exogenous Digestive Enzymes for Intolerances: Oral bacterial/fungal beta-galactosidase (lactase) caplets taken concurrently with dairy meals to cleave lactose; oral porcine diamine oxidase (DAO) capsules taken preprandially to degrade dietary biogenic histamines.
• Phased Elimination-Reintroduction: Unlike absolute lifelong allergen avoidance, intolerances utilize structured temporary elimination followed by gradual challenge titration to establish personal threshold tolerance without compromising dietary diversity.